Vaishali Pharma
Vaishali Pharma Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Vaishali Pharma
Start SIPVaishali Pharma Investment Rating
-
Master Rating:
-
Vaishali Pharma has an operating revenue of Rs. 71.03 Cr. on a trailing 12-month basis. An annual revenue growth of 40% is outstanding, Pre-tax margin of 8% is okay, ROE of 15% is good. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 26% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 62 which is a FAIR score but needs to improve its earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 94 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|
| Oper Rev Qtr Cr | 13 | 10 | 22 |
| Operating Expenses Qtr Cr | 11 | 8 | 25 |
| Operating Profit Qtr Cr | 3 | 2 | 1 |
| Depreciation Qtr Cr | 0 | 0 | 0 |
| Interest Qtr Cr | 1 | 1 | 1 |
| Tax Qtr Cr | 1 | 1 | 0 |
| Net Profit Qtr Cr | 2 | 2 | 0 |
Vaishali Pharma Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- 153.73
- 50 Day
- 150.77
- 100 Day
- 140.02
- 200 Day
- 120.76
- 20 Day
- 160.47
- 50 Day
- 151.55
- 100 Day
- 140.26
- 200 Day
- 115.8
Vaishali Pharma Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 148.67 |
| Second Resistance | 151.24 |
| Third Resistance | 152.57 |
| RSI | 41.32 |
| MFI | 26.39 |
| MACD Single Line | 0.2 |
| MACD | -2.25 |
| Support | |
|---|---|
| First Resistance | 144.77 |
| Second Resistance | 143.44 |
| Third Resistance | 140.87 |
Vaishali Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 93,167 | 6,443,430 | 69.16 |
| Week | 102,935 | 6,630,030 | 64.41 |
| 1 Month | 228,541 | 12,818,841 | 56.09 |
| 6 Month | 258,195 | 12,961,386 | 50.2 |
Vaishali Pharma Result Highlights
Vaishali Pharma Synopsis
NSE-Medical-Diversified
Vaishali Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 75.82 Cr. and Equity Capital is Rs. 10.55 Cr. for the Year ended 31/03/2022. Vaishali Pharma Ltd. is a Public Limited Listed company incorporated on 25/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L52310MH2008PLC181632 and registration number is 181632.| Market Cap | 154 |
| Sales | 71 |
| Shares in Float | 0.77 |
| No of funds | 1 |
| Yield |
| Book Value | 5.85 |
| U/D Vol ratio | 1.4 |
| LTDebt / Equity | 12 |
| Alpha | 0.38 |
| Beta | 0.43 |
Vaishali Pharma
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 26.74% | 26.74% | 26.74% | |
| Foreign Portfolio Investors | ||||
| Individual Investors | 62.85% | 58.58% | ||
| Others | 10.41% | 14.68% | 73.26% |
Vaishali Pharma Management
| Name | Designation |
|---|---|
| Mr. Atul Vasani | Chairman & Managing Director |
| Mr. Dewansh Vasani | Executive Director |
| Mrs. Jagruti Vasani | Whole Time Director |
| Mr. Ashvin Ganatra | Independent Director |
| Mr. Manish Ved | Independent Director |
| Mr. Pratik Jakhelia | Independent Director |
Vaishali Pharma Forecast
Price Estimates
Vaishali Pharma FAQs
What is Share Price of Vaishali Pharma ?
Vaishali Pharma share price is ₹146 As on 28 March, 2023 | 06:45
What is the Market Cap of Vaishali Pharma ?
The Market Cap of Vaishali Pharma is ₹154 Cr As on 28 March, 2023 | 06:45
What is the P/E ratio of Vaishali Pharma ?
The P/E ratio of Vaishali Pharma is 29 As on 28 March, 2023 | 06:45
What is the PB ratio of Vaishali Pharma ?
The PB ratio of Vaishali Pharma is 5.8 As on 28 March, 2023 | 06:45